Is the prophylactic administration of magnesium sulphate in women with pre-eclampsia indicated prior to labour?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 7, 2000, Pages 903-908

  Hall, D R ^a   Odendaal, H J ^a   Smith, M ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; DIHYDRALAZINE; MAGNESIUM SULFATE; NIFEDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CESAREAN SECTION; CONVULSION; DELIVERY; ECLAMPSIA; FEMALE; FETUS DEATH; FETUS DISTRESS; GESTATIONAL AGE; HEADACHE; HUMAN; HYPERTENSION; LABOR; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY TERMINATION; PRIORITY JOURNAL;

ADULT; ANTICONVULSANTS; BLOOD PRESSURE; ECLAMPSIA; FEMALE; GESTATIONAL AGE; HUMANS; LABOR ONSET; MAGNESIUM SULFATE; PRE-ECLAMPSIA; PREGNANCY;

EID: 0034047159     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb11090.x     Document Type: Article

References (20)

1. The Eclampsia Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455–1463.
2. Redman C. Hypertension in pregnancy. In: De Swiet M, editor. Medical Disorders in Obstetric Practice. Oxford: Blackwell Science Publications, 1996: 182–225.
3. Chua S, Redman CW. Are prophylactic anticonvulsants required in severe pre-eclampsia. Lancet 1991; 337: 250–251.
4. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 1994; 309: 1395–1400.
5. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R. editors. Maternal Fetal Medicine: Principles And Practice. Philadelphia: WB Saunders, 1994: 804–843.
6. Duley L, Johanson R. Magnesium sulphate for pre-eclampsia and eclampsia: the evidence so far. Br J Obstet Gynaecol 1994; 101: 565–567.
7. Odendaal HJ, Hall DR. Is magnesium sulphate prophylaxis really necessary in patients with severe preeclampsia J Matern Fetal Invest 1996; 6: 14–18.
8. Mittendorf R, Pryde P, Khosknood B, Lee K. If tocolytic magnesium sulphate is associated with excess total pediatric mortality, what is it's impact Obstet Gynecol 1998; 92: 308–311.
9. Davey DA, MacGillivray I. The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892–898.
10. Coetzee E, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 300–303.
11. Redman CW. Eclampsia still kills. BMJ 1988; 296: 1029–1030.
12. Walker JJ. Care of the patient with severe pregnancy induced hypertension. Eur J Obstet Gynecol Reprod Biol 1996; 65: 127–135.
13. Chen FP, Chang SD, Chu KK. Expectant management in severe preeclampsia: does magnesium sulphate prevent the development of eclampsia Acta Obstet Gynecol Scand 1995; 74: 181–185.
14. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996; 335: 257–265.
15. Abi-Said D, Annegers JF, Combs-Cantrel D, Suki R, Frankowski F, Willmore LJ. A case-control evaluation of treatment efficacy: the example of magnesium sulphate prophylaxis against eclampsia in patients with preeclampsia. J Clin Epidemiol 1997; 50: 419–423.
16. Sibai BM. Eclampsia VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163: 1049–1054.
17. Moodley J, Moodley VV. Prophylactic anticonvulsant therapy in hypertensive crises of pregnancy- the need for a large, randomised trial. Hypertens Preg 1994; 13: 245–252.
18. Lucas MJ, Leveno KJ, Cunningham G. A comparison of magnesium sulphate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201–205.
19. 4therapy in preeclampsia-eclampsia. Obstet Gynecol 1981; 57: 199–202.
20. Leitch CR, Cameron AD, Walker JJ. The changing pattern of eclampsia over a sixty year period. Br J Obstet Gynaecol 1997; 104: 917–922.